Evidence map›Paper›PMID 27873513›Full record

ArticleYonsei medical journal2017

Costs Attributable to Overweight and Obesity in Working Asthma Patients in the United States.

Chongwon Chang, Seung Mi Lee, Byoung Whui Choi, Jong Hwa Song, Hee Song, Sujin Jung, Yoon Kyeong Bai, Haedong Park, Seungwon Jeung, Dong Churl Suh

Open access · goldAbstract read
In one paragraph

Article in Yonsei medical journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 11 citations in OpenAlex.

  1. Effect of Semaglutide and Empagliflozin on Pulmonary Structure and Proteomics in Obese Mice.Diabetes, metabolic syndrome and obesity : targets and therapy · 2024
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Regular follow-up visits reduce the risk for asthma exacerbation requiring admission in Korean adults with asthma.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2018
    Article
  10. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Chongwon ChangCollege of Pharmacy, Chung-Ang University, Seoul, Korea.
Seung Mi LeeCollege of Pharmacy, Chung-Ang University, Seoul, Korea.
Byoung Whui ChoiDepartment of Internal Medicine, College of Medicine, Chung-Ang University, Seoul, Korea.
Jong Hwa SongCollege of Pharmacy, Chung-Ang University, Seoul, Korea.
Hee SongCollege of Pharmacy, Chung-Ang University, Seoul, Korea.
Sujin JungCollege of Pharmacy, Chung-Ang University, Seoul, Korea.
Yoon Kyeong BaiCollege of Pharmacy, Chung-Ang University, Seoul, Korea.
Haedong ParkCollege of Pharmacy, Chung-Ang University, Seoul, Korea.
Seungwon JeungCollege of Pharmacy, Chung-Ang University, Seoul, Korea.
Dong Churl SuhCollege of Pharmacy, Chung-Ang University, Seoul, Korea. dongsuh75@gmail.com.
Chung-Ang University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo estimate annual health care and productivity loss costs attributable to overweight or obesity in working asthmatic patients. MATERIALS AND

methodsThis study was conducted using the 2003-2013 Medical Expenditure Panel Survey (MEPS) in the United States. Patients aged 18 to 64 years with asthma were identified via self-reported diagnosis, a Clinical Classification Code of 128, or a ICD-9-CM code of 493.xx. All-cause health care costs were estimated using a generalized linear model with a log function and a gamma distribution. Productivity loss costs were estimated in relation to hourly wages and missed work days, and a two-part model was used to adjust for patients with zero costs. To estimate the costs attributable to overweight or obesity in asthma patients, costs were estimated by the recycled prediction method.

resultsAmong 11670 working patients with a diagnosis of asthma, 4428 (35.2%) were obese and 3761 (33.0%) were overweight. The health care costs attributable to obesity and overweight in working asthma patients were estimated to be $878 [95% confidence interval (CI): $861-$895] and $257 (95% CI: $251-$262) per person per year, respectively, from 2003 to 2013. The productivity loss costs attributable to obesity and overweight among working asthma patients were $256 (95% CI: $253-$260) and $26 (95% CI: $26-$27) per person per year, respectively.

conclusionHealth care and productivity loss costs attributable to overweight and obesity in asthma patients are substantial. This study's results highlight the importance of effective public health and educational initiatives targeted at reducing overweight and obesity among patients with asthma, which may help lower the economic burden of asthma.

Indexed as

Cost of IllnessEfficiencyEmploymentHealth Care CostsAdultAsthmaFemaleHealth ExpendituresHumansMaleMiddle AgedObesityOverweightUnited StatesYoung AdultAsthmaattributable costsobesityproductivity loss coststreatment costs

Identifiers

PMID27873513
PMCPMC5122636
OpenAlexW2549364716

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.